What Gain Therapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Islam Khalid | Executive Chairman | Aug 09 | Open-market buy · P | +50,000 | $1.00 | +$49.9K | 50,000 |
| Mack Gene | CFO and Interim CEO | Aug 09 | Open-market buy · P | +14,400 | $1.01 | +$14.5K | 14,400 |
| Richman Eric I | Director | Jul 01 | Open-market buy · P | +12,000 | $1.21 | +$14.5K | 289,629 |
| Richman Eric I | Director | Jul 01 | Open-market buy · P | +5,000 | $1.23 | +$6.15K | 277,629 |
| Riley Jeffrey Scott | Director | Mar 28 | Open-market buy · P | +30,000 | $3.86 | +$116K | 30,000 |
| Alder Matthias | Chief Executive Officer | Mar 26 | Withheld — tax / exercise cost · F | −6,085 | $4.06 | −$24.7K | 21,140 |
| Alder Matthias | Chief Executive Officer | Mar 26 | Exercise / conversion · M | +637 | — | — | 27,225 |
| Alder Matthias | Chief Executive Officer | Mar 26 | Exercise / conversion · M | +825 | — | — | 26,588 |
| Alder Matthias | Chief Executive Officer | Mar 26 | Exercise / conversion · M | +18,750 | — | — | 25,763 |
| Alder Matthias | Chief Executive Officer | Dec 21 | Open-market sale · S | −206 | $2.46 | −$507 | 5,286 |
| Alder Matthias | Chief Executive Officer | Dec 20 | Exercise / conversion · M | +637 | — | — | 5,492 |
| Alder Matthias | Chief Executive Officer | Dec 07 | Sale for tax withholding · S | −1,820 | $2.50 | −$4.55K | 4,855 |
| Alder Matthias | Chief Executive Officer | Oct 01 | Exercise / conversion · M | +825 | — | — | 6,675 |
| Richman Eric I | Director | Sep 20 | Exercise / conversion · M | +54,900 | — | — | 272,629 |
| Alder Matthias | Chief Executive Officer | Sep 20 | Exercise / conversion · M | +2,550 | — | — | 5,850 |
| Alder Matthias | Chief Executive Officer | Jul 01 | Exercise / conversion · M | +3,300 | — | — | 3,300 |
| Richman Eric I | CHIEF EXECUTIVE OFFICER | May 25 | Open-market buy · P | +2,482 | $2.58 | +$6.4K | 217,729 |
| Richman Eric I | CHIEF EXECUTIVE OFFICER | May 20 | Open-market buy · P | +9,256 | $2.83 | +$26.2K | 215,247 |
| Calabrese Salvatore | CHIEF FINANCIAL OFFICER | May 19 | Open-market buy · P | +3,000 | $2.70 | +$8.1K | 3,000 |
| Richman Eric I | CHIEF EXECUTIVE OFFICER | May 19 | Open-market buy · P | +4,000 | $2.71 | +$10.8K | 205,991 |
Loading...
